












































































































































data	 from	 ePAQ-PF	 were	 collected	 prospectively	 from	 60	 women	 undergoing	 vaginal	
hysterectomy	 for	 prolapse.	Of	 these,	 20	were	normal	weight	 (BMI	 18.5	 –	 24.9),	 20	were	
overweight	 (BMI	 25	 –	 29.9)	 and	 20	 were	 women	 with	 obesity	 (BMI	 30	 –	 34.9).	 	 The	
relationship	between	BMI	and	symptom	scores	for	prolapse,	impact	on	vaginal	symptoms	on	
quality	 of	 life	 and	 ‘overall	 change	 in	 condition’	 was	 assessed.	 Pre-	 and	 post-operative	
symptom	scores	were	compared	using	repeated	mixed	ANOVA	test	for	BMI	as	a	categorical	
variable	 (Normal,	 Overweight	 and	 Obese).	 Spearman’s	 rank	 order	 correlation	 test	 was	







































Paper	 4	 (development/testing	 of	 ePAQ-Menstrual,	 Pain	 and	 Hormonal	 (ePAQ-MPH)):	
Exploratory	 factor	 analysis	 identified	18	domains	 (Cronbach’s	α	>0.7)	 and	30	 redundant	
items.	 Test-retest	 analysis	 found	 acceptable	 intra-class	 correlations	 of	 0.6–0.9	 (p<0.05).	
Eight	domains	were	compared	with	Menstrual	Distress	Questionnaire	showing	moderate	or	
strong	 correlation	 in	 seven	domains.	Ten	domains	were	 compared	with	Women’s	Health	
Questionnaire,	six	of	which	showed	moderate	correlation.	Mean	QQ-10	Value	and	Burden	


























Conclusions:	 This	 narrative	 thesis	 presents	 good	 evidence	 for	 the	 use	 of	 ePROMs	 in	
gynaecology,	 both	 as	 clinical	 and	 research	 tools.	 Electronic	 patient	 reported	 outcome	
measures	 in	 gynaecology	 have	 an	 important	 role	 in	 supporting	 self-	 expression	 and	
increasing	disclosure	of	potentially	taboo	or	embarrassing	symptoms.	Their	use	as	research	
tools	 is	 valuable	 allowing	 symptom	 complexes	 to	 be	 explored	 and	 outcomes	 after	
















AMED			 	 	 Allied	and	complimentary	MEdicine	Database	
ANOVA		 	 	 Analysis	of	Variance	
BMI		 	 	 	 Body	Mass	Index	
CINAHL	 	 	 Cumulative	Index	to	Nursing	and	Allied	Health	Literature	
EMBASE	 	 	 Excerpta	Medica	dataBase	
ePAQ		 	 	 	 Electronic	Personal	Assessment	Questionnaire	
ePAQ-MPH	 Electronic	Personal	Assessment	Questionnaire-	Menstrual,	
Pain	and	Hormonal	
ePAQ-PF		 	 	 Electronic	Personal	Assessment	Questionnaire-	Pelvic	Floor	
ePAQ-Vulva	 	 	 Electronic	Personal	Assessment	Questionnaire-	Vulva	 	
ePROM		 	 	 Electronic	patient	reported	outcome	measure	
HRQoL	 	 	 Health-related	Quality	of	Life	
MCQ		 	 	 	 Multiple	Choice	Question	
OAB	 	 	 	 Overactive	bladder	
POP	 	 	 	 Pelvic	organ	prolapse	
POP-Q		 	 	 Pelvic	organ	prolapse	Quantification	system	
PRISMA		 Preferred	Reporting	Items	for	Systematic	reviews	and	meta-
Analysis	
PROM	 	 	 	 Patient	reported	outcome	measure	
	
11	
QQ-10		 	 	 Questionnaire	Quotient	-10	item	















































I	 undertook	 data	 collection	 and	 analysis	 for	 version	 2	 of	 ePAQ-MPH,	 including	 for	 the	
confirmatory	 factor	 analysis	 alongside	 Professor	 Jones.	 I	 reviewed	 and	 restructured	 the	















































































































































assess	 both	 the	 frequency	 and	 impact	 of	 pelvic	 floor	 symptoms	 across	 four	 dimensions:	









The	 electronic	 instrument	 automatically	 generates	 scores	 across	 20	 validated	 domains	











Five	of	 the	papers	 incorporated	 into	this	narrative	thesis	are	studies	which	use	the	ePAQ	
system	developed	for	ePAQ	Pelvic	Floor.	Two	of	the	studies	describe	the	development	and	
initial	psychometric	testing	of	two	novel	gynaecology	ePROMs	using	the	ePAQ	base	format	
for	 software	 engineering	 and	 PROM	 production.	 Three	 further	 papers	 utilise	 data	 from	












































































































































































idea	 of	 an	 electronic	 PROM	 to	 aid	with	 the	 assessment	 of	with	 vulval	 disorders,	 74%	of	
patients	 listed	 advantages	 ePROMs	 in	 this	 context,	 compared	 to	 26%	 who	 listed	





not	 involved	 in	 assessments	 of	 reading	 level	 for	 the	 ePAQ-Vulva	 PROM	 and	 were	 only	
involved	at	the	very	start	of	PROM	production.	Given	the	evidence	for	the	benefits	of	patient	





ePROM	 designed	 to	 assess	 menstrual	 disorders,	 gynaecological	 pain	 syndromes	 and	



































































































































Factor	 analysis	 indicated	 the	 presence	 of	 five	 components	 or	 domains.	 The	 expert	 panel	
reviewed	and	intuitively	amended	these	components	to	provide	a	structure	comprising	of	
six	clinically	meaningful	domains.	Internal	reliability	of	the	six	domains	was	assessed	using	
Cronbach’s	α;	all	six	domains	achieved	an	alpha	 level	of≥	0.7.	 Inter-rater	reliability	of	 the	
picture	items	showed	agreement	between	clinician	and	patient	54%	of	the	time	regarding	
the	 presence	 of	 symptoms.	 	 Agreement	 regarding	 absence	 of	 symptoms	 was	 85%.	 The	
Cohen’s	 Kappa	measure	 of	 agreement	 for	 this	 was	moderate	 at	 0.405.	 Spearman’s	 rank	
showed	significant	moderate	correlation	between	multiple-choice	components	and	free-text	
items	 in	 three	 of	 the	 five	 domains.	 The	 initial	 testing	 and	 validation	 of	 ePAQ-Vulva	 has	
provided	some	evidence	of	reliability	and	validity	but	the	data	analysed	so	far	represent	a	
relatively	 small	 sample	 in	 a	 single-centre	 specialist	 vulval	 clinic.	 ePAQ-Vulva	 therefore	
requires	 further	 testing,	 including	confirmatory	 factor	analysis	of	 its	domain	structure	 in	
larger	numbers	of	women.	Changes	will	be	made	to	the	 instrument	to	remove	redundant	
items,	 though	 with	 some	 caution	 to	 ensure	 that	 clinical	 detail	 is	 not	 lost	 through	 item	
























Complete	 questionnaire	 data	 were	 obtained	 from	 291	 completions	 of	 ePAQ-MPH.	 Mean	
completion	 time	was	31	minutes.	Eighteen	domains	of	ePAQ-MPH	with	Cronbach’s	alpha	
values	of	>0.7	were	identified.	Factor	analysis	demonstrated	that	the	Menstrual	dimension	












was	not	achieved	 in	 the	hormonal	/	sexual	 function	domain	(0.45).	 Interclass	correlation	
>0.5	was	seen	 in	all	other	domains.	For	criterion	validity	of	Version	1	of	ePAQ-MPH,	180	
patients	 completed	 the	MDQ	 PROM	 and	 213	 completed	 the	WHQ	 PROM.	 Two	 of	 the	 18	
domains	 of	 ePAQ-MPH	 (Version	 1)	 had	 a	 relevant	 domain	 in	 both	MDQ	 and	WHQ.	 Eight	
domains	 were	 compared	 with	 MDQ	 showing	 moderate	 or	 strong	 correlation	 in	 seven	















retest	 reliability	 and	 criterion	validity.	The	 results	of	 the	 initial	psychometric	 testing	has	
enabled	 remodelling	 of	 the	 instrument.	 The	 confirmatory	 factor	 analysis	 of	 the	 revised	
instrument	has	shown	that	the	domain	structure	of	ePAQ-MPH	fits	the	data	it	is	intended	to	
collect	 moderately	 well	 and	 good	 model	 fit	 was	 also	 demonstrated,	 confirming	 the	
conceptual	 framework	 of	 the	 instrument.	 Whilst	 this	 paper	 reports	 the	 development	 of	
version	3	of	ePAQ-MPH,	to	allow	other	research	groups	to	scrutinise	and	review	the	data	



















































can	be	 further	divided	 into	 coital	 incontinence	occurring	with	penetration	at	 the	 start	 of	
intercourse	and	that	occurring	at	orgasm58.	The	aim	of	the	study	was	to	accurately	measure	
the	 prevalence	 of	 coital	 incontinence	 in	women	 attending	 the	 urogynaecology	 clinic	 and	
evaluate	the	association	between	different	types	of	coital	incontinence	and	different	types	of	
urinary	incontinence	(stress	incontinence	and	overactive	bladder)	and	HRQoL.	Previously	it	
was	 thought	 that	 coital	 incontinence	 at	 orgasm	 was	 due	 to	 overactive	 bladder	 (OAB)	
(inappropriate	bladder	contractions	causing	leakage)	and	that	incontinence	at	penetration	





showed	 that	 the	 prevalence	 of	 coital	 incontinence	 in	 the	 cohort	was	 30%.	 Symptoms	 of	
overactive	 bladder	 (p<0.005)	 and	 stress	 urinary	 incontinence	 (p<0.005)	 were	 both	
significantly	and	independently	associated	with	both	types	of	coital	incontinence	(orgasm	&	
penetration).	This	was	 in	 contrast	 to	 the	previously	held	view	 that	 coital	 incontinence	at	
orgasm	was	 only	 associated	with	 overactive	 bladder.	 In	women	with	 coital	 incontinence	
compared	 with	 those	 without,	 there	 was	 significant	 self-avoidance	 of	 sex	 (p<0.0005),	
partner-avoidance	of	sex	(p<0.0005)	and	impaired	quality-of-sex-life	due	to	sexual	problems	
(p<0.005).	The	impact	of	this	was	significant	in	each	group.	Therefore,	the	symptom	of	coital	


















as	 a	 categorical	 variable	 (Normal,	 Overweight	 and	 Obese).	 Spearman’s	 rank	 order	
correlation	 test	 was	 carried	 out	 to	 evaluate	 BMI	 as	 a	 continuous	 variable.	 All	 women	
























hysterectomy	 for	 prolapse	 has	 permitted	 a	 detailed	 comparison	 of	 subjective	 outcomes	
between	different	BMI	groups	in	this	small	study.		The	main	recommendation	following	this	
small	study	could	be	that,	because	women	with	increasing	BMI	are	likely	to	be	satisfied	to	a	
lesser	 degree	with	 the	 outcome	 of	 prolapse	 surgery,	 they	 should	 perhaps	 be	 counselled	
about	 this	 pre-operatively;	 or	 else	 weight	 loss	 prior	 to	 surgery	 be	 recommend.	 Future	
studies	 in	 this	 area	 should	 investigate	 the	 impact	 of	 obesity	 on	 outcomes	 of	 surgery	 for	



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Paper-based	 1	 English	 -	
St	Marks	Score	 Maeda	at	el,	
2007	





































































Validated questionnaire/PROM 1 100% 21% 
Non-validated questionnaire 7 92%±0.2% 22%±0.2% 
Patient interview (telephone/face to face) 3 66%±0.4% 16%±0.1% 
Studies	with	follow	up	after	6/52	up	to	1	year	after	childbirth 
Validated questionnaire/PROM 16 65%±0.4% 27%±0.3% 
Non-validated questionnaire 18 76% 0.3% 21% 0.4% 
Patient interview (telephone/face to face) 17 74%±0.2% 12%±0.2% 
Studies	with	follow	up	between	2-5	years	after	childbirth 
Validated questionnaire/PROM 6 66%0.5% 33%±0.2% 
Non-validated questionnaire 10 74%±0.2% 38%±0.3% 
Patient interview (telephone/face to face) 0 No Data No Data 
Studies	with	follow	up	at	greater	than	5	years	after	childbirth 
Validated questionnaire/PROM 12 62%±0.3% 26%±0.3% 
Non-validated questionnaire 11 68%±0.3% 31%±0.4% 






















Table 3: Comparison of mean prevalence rates reported for anal incontinence using validated 














T value P	value	 95%		
Confidence	
interval	













2-5 years 33%±0.2% 
(6 studies) 
No data - -	 -	








Table 4: Comparison of mean prevalence rates reported for anal incontinence using non-validated 














T value P	value	 95%	
Confidence	
interval	












2-5 years 38%±0.3% 
(10 studies) 
No data - -	 -	









Table 5: Comparison of mean prevalence rates reported for anal incontinence using validated 















T value P	value	 95%	
Confidence	
interval	






























From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-






























































































































































































































































































































































































































































































Primiparous women (all modes of delivery) 
Follow up to 6/52 or less 













Non-reported 6% Not reported Not reported 20% 










100% 18.4% 10.5% 2.6% 18.4% 










100% 15.4% Not reported 10.2% 24% 
Follow up > 6/52 to 1 year 










92% 17% Not reported 3% 17% 











56% 12.4% 1.8% 0.6% 12.4% 








96% 13.8% 4.1% 4.1% 15% 










52% Not reported Not reported Not reported 20.6% 











29% Not reported Not reported Not reported 21.7% 











80% 26% Not reported Not reported 26% 























85% 48% 18% 5% 48% 
Follow up 2-5 years 










70% 27.4% 18.8% 10.2% 27.4% 











69% 34.2% Not reported 
separately 
4.9% 35.5% 











81% 31% Not reported 
separately 
5.6% 46% 











65.2% Not reported Not reported Not reported 13.3% 










52.8% 26% 8.6% 1.6% 26% 
Postnatal women (all parities and modes of delivery) 
Follow up to 6/52 or less 
Rajeshkannan at 
al, 2013 
2 Postnatal women 
(all parities and 
540 6 weeks Self-
administered 













Hall et al, 2003 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 




96% 24% Not reported 10% 24% 
Abramowitz et 
al, 2000 
3 Postnatal women 
(all parities and 
modes of 
delivery) 




90% 10.4% 1.4% 1.8% 10.4% 
Follow up > 6/52 to 1 year 
Hannah et al, 
2002 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 




82% 7.8% Not reported 0.9% 7.8% 
Haadem et al, 
1990 
2 Postnatal women 
(all parities and 
modes of 
delivery) 




!00% 25% Not reported 2.7% 25% 
MacArthur et al, 
2001 
2 Postnatal women 
(all parities and 
modes of 
delivery) 




71.7% 45.3% Not reported 9.6% 45.3% 
Eason et al, 2002 2 Postnatal women 
(all parities and 
modes of 
delivery) 




79% 25.5% Not reported 3.1% 25.5% 
Obioha et al, 
2015 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 




92% 10.4% Not reported 
separately 
3% 13.5% 
Glazener et al, 
1995 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 








86% Not reported Not reported Not reported 0.2% 
Follow up 2-5 years 
Palm et al, 2013 
 
2 Postnatal women 








69.2% 59% 18.4% 6% 59% 
Follow up > 5 years 
Ryhammer et al, 
1995. 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 




80% 4.95% Not reported 0.8% 4.95% 
Fornell et al, 
2005 
2 Postnatal women 
(all parities and 
modes of 
delivery) 




71% 13% 14.6% 21.9% 13% 
Glazener et al, 
2014 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 






63% Not reported Not reported Not reported 16.5% 
MacArthur et al, 
2011 
 
1 Postnatal women 
(all parities and 
modes of 
delivery) 




49% Not reported Not reported Not reported 12.9% 
Nygaard et al, 
1997 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 




67% 68% Not reported 41% 68% 
Bollard et al, 
2003 
2 Postnatal women 
(all parities and 
modes of 
delivery) 




64% 31% 6% 4.4% 64% 
Variable follow up 
McKinnie et al, 
2005 
2 Postnatal women 
(all parities and 
modes of 
delivery) 











Goldberg et al, 
2003 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
All had multiple 
pregnancy 




95.3% 25.2% 5.9% 1.6% 25.2% 
Kunduru et al, 
2015 
2 Postnatal women 







100% Not reported Not reported Not reported 14.2% 
Postnatal women with obstetric anal sphincter injury 

















68% 41% 8.8% Not reported 41% 
Follow up > 6/52 to 1 year 
Haadem et al, 
1988 
2 Postnatal women 
with obstetric 
59 3 months Self- 
administered 







Chaliha et al, 
1999 
 









Not reported 4.9% 0.5% 0.4% 5% 
Uustal Fornell et 
al, 1996  









94% 24% 16% 0% 40% 
Mazouni et al, 
2005 
2 Postnatal women 
after instrumental 
delivery 




75% 7.5% Not reported Not reported 8.8% 
Follow up 2-5 years 
Tetzschner et al, 
1997 
 








77% 25% Not reported 17% 25% 
Haadem et al, 
1987 








95% 25.4% Not reported 6.7% 50.9% 
Gjessing et al , 
1998 
 








75% 34% 11.4% 11.4% 57% 








60% 26% 19.5% 4.9% 37% 
Poen et al, 1998 
 








75% 19.6% 5.1% 7% 40%  
Follow up > 5 years 
Sørensen et al, 
1988 








96% 25% 13% 4% 42% 
de Leeuw et al, 
2002 








Not reported 35% 21% 24% 35% 
Postnatal women following instrumental delivery 
Sultan et al, 
1998 
 








73.8% 22.7% 11.3% 3.6% 22.7% 
Johanson et al, 
1999 




























































149	 9-11	weeks	 Patient	interview	 80%	
	









































































































































































































































rate ± 2SD 
Validated questionnaire/symptom scale (validated patient reported outcome measures) 
6 weeks or less 1 200 100% 100% 





2-5 years 6 4236 66% 80%±0.5 
>5 years 12 15144 64% 62%±0.1 
Non-validated questionnaires 
6 weeks or less 7 1257 96% 92%±0.2 
>6 weeks to 1 
year 
18 15766 81% 76%±0.4 
2-5 years 10 1685 75% 74%±0.2 
>5 years 11 11425 66% 69%±0.3 
Patient interview 
6 weeks or less 3 353 74% 66%±0.4 
>6 weeks to 1 
year 
17 7175 80% 74%±0.3 
2-5 years     













































































picture	 (body	 image)	 that	 an	 individual	 has	 of	 his	 or	 her	 external	 genitalia	 [4]	 and	may	






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Objective:	 Development	 of	 an	 electronic	 patient	 reported	 outcome	 measure	 (PROM)	




61	 vulval	 clinic	 patients.	 The	 PROM	 assesses	 frequency	 and	 impact	 of	 vulval	 symptoms,	
















Conclusions:	 ePAQ-Vulva	 offers	 the	 first	 patient	 reported	 outcome	 tool,	 specifically	
designed	 for	 vulval-disorders.	 The	 instrument	 requires	 further	 validation	 and	 testing,	
including	evaluation	of	the	stability,	responsiveness	and	reliability.	
		

































image,	 self-confidence,	 relationships	 and	 sexual	 function.2	 Adequate	 consultation	 time	 is	
essential	 to	enable	appropriate	assessment	of	women	with	vulval-disorders.	New-patient	
appointments	within	the	National	Health	Service	(NHS)	in	the	UK	are	restricted	to	twenty-
minutes.	 Taking	 a	 detailed	 history,	 physical	 examination,	 scheduling	 investigations,	
discussing	possible	diagnoses	and	treatment	options,	whilst	making	provision	for	women	to	
freely	express	themselves	about	such	intimate	conditions	is	challenging.				
Patient-reported	 outcome	 measures	 (PROMs)	 are	 questionnaires	 or	 instruments	



















The	 available	 instruments	 are	 therefore	 either	 specific	 to	 vulval	 cancer	 or	 non-
specific	 to	 the	 vulva	 itself.	 The	 now	 archived	 Royal	 College	 of	 Obstetricians	 and	
Gynaecologists	(RCOG)	Guideline	on	the	Management	of	Vulval	Skin	Disorders	included	an	
example	of	 a	pre-clinic	 vulval-disorders	questionnaire.14	This	 explores	behaviors	 and	 co-
morbidities	that	relate	to	vulval-disorders,	but	does	not	include	assessment	of	symptoms,	
sexual	function	or	quality-of-life.		
The	 first	 aim	of	 this	 study	was	 to	develop	 a	PROM	 instrument	 specific	 for	 vulval-
disorders,	utilizing	 the	potential	benefits	of	an	 interactive	electronic	 format	 in	evaluating	
intimate	 and	 sensitive	 conditions,	 enhancing	 patient	 assessment	 and	 addressing	 the	
collection	 of	 PROMs	 data.	 The	 second	 aim	was	 to	 undertake	 psychometric	 testing	 of	 the	

























The	 platform	 technology	 used	 was	 first	 developed	 in	 urogynaecology	 to	 assess	
women	 with	 pelvic-floor	 disorders	 (ePAQ-Pelvic	 Floor),	 which	 has	 been	 extensively	
validated	and	used	in	clinical	practice.15-17		
Key	elements	of	 the	system	 include	 introductory	pages,	explaining	how	to	use	 the	
‘Help’,	‘Back’,	‘Next’	and	‘Skip’	navigation	functions.	This	eliminates	accidental	non-response	
to	 items,	as	progression	 is	only	enabled	once	a	 response	has	been	selected.	 Items	can	be	
skipped	 automatically,	 depending	 upon	 responses	 to	 earlier	 screening	 questions.	 Sub-








Food	 and	 Drug	 Administration	 (FDA)	 guidance	 on	 PROM	 development.18	 Content	 was	
informed	 by	RCOG	 guidelines	 for	 the	management	 of	 vulval-disorders,	 findings	 from	 the	





prepared	 across	 six	 drafts,	 before	 converting	 to	 electronic	 format	 using	 the	 ePAQ	





















symptoms,	 sexual	 function	 and	 quality	 of	 life;	 the	 instrument	 was	 administered	 to	
consenting	 patients	 attending	 the	 vulval	 clinic	 at	 Sheffield	 Teaching	 Hospitals	 NHS	








private	 room.	 Data	 from	 each	 subject	 automatically	 populates	 a	 one-page	 summary	 and	













































related,	 are	 in	 fact	 related.	This	was	partially	 assessed	by	 comparing	 the	multiple-choice	
responses	with	 the	 free-text	 items	 recording	 subject’s	 concerns	 and	 goals.	 The	 free	 text	
comments	were	each	reviewed	to	assess	if	the	concern	recorded	by	the	patient	was	assessed	
by	 a	 questionnaire	 item	 in	 a	 particularly	 domain.	 Free-text	 data	 for	 concerns	were	 then	














about	 vulval-disorders	 (33%).	 When	 asked	 about	 possible	 advantages	 of	 an	 electronic	







































































The	 six	 components	 resulting	 from	Factor	Analysis,	 Internal	 reliability	 testing	 and	

























in	 sensitive	 conditions	 and	 that	 patients	 may	 feel	 more	 comfortable	 exploring	 sensitive	





The	 initial	 testing	 and	 validation	 of	 ePAQ-Vulva	 has	 provided	 some	 evidence	 of	





affect	 compliance	 with	 questionnaire	 completion.	 25	 Important	 psychometric	 properties,	
including	 test-retest	 reliability	 (stability),	 local	 dependency,	 item	 discrimination	 and	
responsiveness	of	the	instrument	have	yet	to	be	evaluated.		
Of	 the	 six	 domains	 in	 the	 vulval	 symptoms	 dimension	 of	 ePAQ-Vulva,	 both	 skin	
changes	and	quality	of	life	did	not	reach	statistical	significance	in	this	study.	This	could	be	
due	to	a	lack	of	direct	patient-involvement	in	the	construction	of	the	questionnaire	items.	
Whilst	 some	 patient	 involvement	 supported	 initial	 development	 and	 testing	 of	 the	
instrument,	due	to	the	limited	time-frame	of	the	study,	qualitative	in-depth	interviews	with	
patients	were	not	carried	out.3	Further	work,	such	as	cognitive	interviewing	with	patients	is	














Further	 research	 is	 required	 to	 better	 understand	 their	 reliability	 and	 value	 in	 clinical	
practice.		Only	fair	inter-rater	reliability	was	demonstrated	in	this	initial	study.	








domains	 may	 be	 particularly	 helpful	 in	 monitoring	 long-term	 vulval	 conditions	 when	
reviewing	patients	at	follow-up	appointments.	
The	 instrument	 aligns	 with	 BSSVD	 recommended	 standards	 of	 care	 through	 the	
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V4a	-	Painkiller	use	 	 97	 0	 0	 .46	 63	 25	 7	 2	
V5a	–	Micturition	pain	 	 97	 1	 1	 .85	 33	 51	 8	 5	































V10a	–	Itching	and	excoriation	 	 95	 1	 1	 1.03	 31	 39	 15	 9	
V11a	–	Itching:	scratching	and	
bleeding	
	 95	 0	 0	 .41	 63	 26	 5	 1	






























V14a	–	Skin	dryness	 	 95	 0	 1	 1.33	 34	 15	 27	 19	
V15a	–	Skin	tightness	 	 95	 0	 1	 1.13	 41	 21	 12	 20	
V16a	–	Skin	thickening	 	 94	 0	 0	 .48	 63	 15	 6	 5	








































V25a	–	Dyspareunia:	post	coital	 	 92	 1	 1	 1.49	 15	 19	 12	 17	
V26a	–	Dyspareunia:	dryness	 	 92	 0	 1	 1.46	 21	 13	 8	 21	
V27a	–	Dyspareunia:	reduced	
sensation	
	 92	 0	 1	 1.08	 23	 12	 8	 13	
V28a	Dyspareunia:	tightness	 	 92	 0	 1	 1.24	 26	 14	 8	 16	































V31a	Vulva	and	sex	avoidance	 	 91	 3	 2	 1.91	 9	 16	 12	 29	
V32a	Vulva	and	sex	partner	avoids	 	 91	 0	 1	 1.27	 26	 12	 10	 16	




































































































Table 3: Internal reliability assessment of the six domains on ePAQ-Vulva:	The	
6	 components	 resulting	 from	 Factor	 Analysis,	 Internal	 reliability	 testing	 and	






































































Menstrual	 disorders,	 pelvic-pain	 and	 gynaecological	 hormonal	 conditions	 in	 women	 can	
have	 a	 significant	 impact	 on	 quality-of-life.	 Reliable	 assessment	 and	monitoring	 of	 these	
intimate	 conditions	 is	 challenging.	 Patient	 reported	 outcome	 measures	 (PROMs)	 can	 be	
invaluable	in	providing	objective	assessment,	but	no	comprehensive	PROM	assessing	all	of	
these	conditions	and	their	impact	on	quality	of	life	is	currently	available.	The	purpose	of	this	






factor	 analysis	 was	 undertaken	 in	 291	 women	 attending	 a	 menstrual-disorders	 clinic;	









Exploratory	 factor	 analysis	 identified	18	domains	 (Cronbach’s	α	>0.7)	 and	30	 redundant	
items.	 Test-retest	 analysis	 found	 acceptable	 intra-class	 correlations	 of	 0.6–0.9	 (p<0.05).	
Eight	domains	were	compared	with	Menstrual	Distress	Questionnaire	showing	moderate	or	
strong	 correlation	 in	 seven	domains.	Ten	domains	were	 compared	with	Women’s	Health	
Questionnaire,	six	of	which	showed	moderate	correlation.	Mean	QQ-10	Value	and	Burden	
scores	were	 76	 and	 25,	 respectively	 (SD=15.8	 and	 15.5).	 The	mean	 completion	 time	 for	
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conditions,	 where	 patients	 may	 not	 disclose	 embarrassing	 symptoms	 is	 potentially	
invaluable	[10-12].	
A	number	of	PROMs	have	been	described	for	use	in	women	with	menstrual,	pelvic	pain	and	
gynaecological	 hormonal	 disorders.	 However,	 existing	 instruments	 are	 either	 condition	
specific	 [13-15]	 or	 limited	 to	 one	 symptom	 area	 of	 menstrual	 disorders;	 specifically	
assessing	heavy	menstrual	bleeding,	 [16-18]	pelvic	pain,	 [19]	sexual	 function,	 [20]	health	
related	 quality-of-life	 [21-24]	 or	 premenstrual	 syndrome	 alone.	 [25-28].	 The	majority	 of	























systematic	 literature	 review	 of	 existing	 women’s	 health	 PROMs	 and	 semi-structured	
interviews	 with	 25	 patients	 conducted	 by	 a	 social	 scientist	 experienced	 in	 PROM	






























Internal	 reliability	 is	 the	 extent	 to	which	 items	within	 an	 instrument	measure	 the	 same	
concepts	[34].	It	also	ensures	that	no	two	items	are	measuring	exactly	the	same	concept	and	
may	be	used	as	a	 tool	 for	 item	reduction.	Cronbach’s	α	was	used	 to	measure	 this;	 scores	






























2017,	 Los	 Angeles,	 CA)	 was	 undertaken	 on	 254	 completed	 questionnaires	 (ePAQ-MPH	



















ePAQ-MPH	 is	 completed	 online;	 patients	 use	 a	 unique	 16-digit	 voucher	 code	 which	 is	
automatically	generated	and	embedded	in	a	posted	clinic	letter.	This	code	is	entered	by	the	






Each	 item	 is	 presented	 on	 one	 screen	 and	 presents	 stem	questions	 relating	 to	 symptom	
frequency	and	severity,	sub-questions	regarding	the	impact	of	symptoms	are	displayed	if	the	
particular	 symptom	 is	 reported.	 Each	 item	 offers	 a	 four-point	 response	 scale	 (Figure	 1).	
Domain	scores	are	computed	using	a	standard	algorithm	used	in	the	urogynaecology	version	
of	ePAQ,	providing	scales	from	0	(best	health	status)	to	100	(worst	heath	status).	Responses	





























































for	 the	majority	of	patients.	Of	 the	six	 items	relating	 to	Value,	 ‘ease	of	use’	and	 ‘happy	to	
complete	again’	were	the	most	highly	rated	responses	(92%	and	90%,	respectively).	Of	the	









overall	model	did	not	 fit	 the	data	well;	as	should	be	expected	 from	this	 test	 for	CFA.	The	














ePAQ-MPH	 is	 a	 condition-specific	 ePROM	 which	 provides	 comprehensive	 assessment	 of	
symptomatology	 associated	 with	 menstrual	 disorders,	 pelvic	 pain	 and	 gynaecological	
hormonal	conditions	and	their	associated	impact	on	sexual	function	and	quality	of	life.		
ePAQ-MPH	 combines	 detailed	 assessment	 of	 menstrual	 disorders,	 including	 heavy	
menstrual	bleeding,	cycle	regularity,	 intermenstrual	bleeding,	dysmenorrhea,	menopausal	
symptoms	and	pre-menstrual	syndrome.	The	PROM	also	assesses	non-cyclical	pelvic	pain	















Initial	 psychometric	 testing	 of	 ePAQ-MPH	has	 shown	 good	 internal	 reliability,	 test-retest	
reliability	and	criterion	validity.	The	results	of	the	initial	psychometric	testing	has	enabled	
remodelling	of	the	instrument.	The	confirmatory	factor	analysis	of	the	revised	instrument	
has	 shown	 that	 the	 domain	 structure	 of	 ePAQ-MPH	 fits	 the	 data	 it	 is	 intended	 to	 collect	






particularly	 in	 under-resourced	 clinics	 when	 patients	 have	 failed	 to	 pre-complete	 the	














HRQoL	 rather	 than	 symptomology	 [35,	 36]	 therefore	 the	 domains	 compared	 were	 not	
directly	measuring	an	identical	concept.	As	this	was	a	research	project,	requiring	consent,	
women	who	were	 participants	may	have	 been	more	motivated	 to	 provide	 questionnaire	


































































































































































































































































































Regularity		 0.87	(280)	 0.87	(27)	 0.87	












Dysmenorrhoea	 0.83	(249)	 0.82	(26)	 0.80	
Non-cyclical	pain	 0.79	(210)	 0.73	(19)	 0.88	
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Coital incontinence is the involuntary leakage of urine during sexual intercourse and is divided 
into that occurring with penetration or orgasm. Mechanisms of coital incontinence are poorly 
understood. The aim of this retrospective study was to measure the prevalence of coital 
incontinence and evaluate the association between different types of coital incontinence with stress 
urinary incontinence (SUI), overactive bladder (OAB) and impact on quality-of-life in women 
attending a urogynaecology clinic.  
 
Methods 
2312 women completed ePAQ-PF in advance of their urogynaecology consultation. Logistic 
regression and Spearman’s rank correlation evaluated associations between types of coital 
incontinence and OAB and SUI. Mann-Witney test evaluated the relationship between coital 
incontinence and self-reported quality-of–sex-life and self -avoidance and partner-avoidance of 




Prevalence of coital incontinence in the cohort was 30%. Symptoms of OAB (p<0.005) and SUI 
(p<0.005) were significantly and independently associated with both types of coital incontinence 
(orgasm & penetration). In women with coital incontinence compared with those without, there 
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was significant self-avoidance of sex (p<0.0005), partner-avoidance of sex (p<0.0005) and 
impaired quality-of-sex-life due to sexual problems (p<0.005). The impact of this was significant 
in each group. Subgroup analysis of 84 women undergoing TVT showed significant 
improvement in all coital incontinence symptoms three months post-operatively. 
 
Conclusion Using an electronic questionnaire prior to consultation has identified coital 
incontinence as a prevalent symptom, having a significant impact on sexual life. Coital 
incontinence at orgasm and penetration are both significantly associated with SUI and OAB. 
 
Keywords: coital incontinence, ePAQ-PF, questionnaire, computer interviewing, TVT, orgasm 
 
Brief Summary:  
Orgasm and penetration coital incontinence are prevalent complaints in women attending 













Coital incontinence is a symptom occurring within the spectrum of urinary incontinence in 
women and is defined as the complaint of involuntary loss of urine associated with coitus. This 
can be further divided into coital incontinence occurring with penetration and that occurring at 
orgasm[1]. 
Coital incontinence is prevalent in women attending urogynaecology clinics [2, 3, 4] and has 
been shown to affect up to 60% of women with urinary incontinence [5]. Coital incontinence has 
been shown to have a negative impact on quality of life [6]. 
 The precise mechanism and aetiology of coital incontinence remains incompletely understood, 
with conflicting evidence presented in previous studies regarding the association between coital 
incontinence and stress urinary incontinence (SUI) and detrusor overactivity (DO). Previously, it 
has been observed in urodynamic studies that coital incontinence with orgasm was more strongly 
associated with detrusor overactivity (DO), whereas coital incontinence with penetration more 
strongly associated with urodynamic stress incontinence (USI)  [2, 7]. However, larger studies 
have suggested that urodynamic findings do not correlate well with orgasm or penetration coital 
incontinence [5, 8]. 
 
The objective of this study was to evaluate the prevalence of coital incontinence in women 
attending a urogynaecology clinic in a tertiary teaching hospital in the UK, and evaluate the 
association between different types of coital incontinence and SUI, OAB and quality of life. The 
impact of treatment with tension-free vaginal tape (TVT) on coital incontinence will be assessed 






Women attending the urogynaecology unit at Sheffield Teaching Hospitals, UK, between 
January 2012 and September 2015 who had completed the electronic Personal Assessment 
Questionnaire-Pelvic Floor (ePAQ-PF) as part of their routine clinical care, prior to first 
assessment in the urogynaecology clinic, were included in the study. Ethical approval for this 
study was obtained from the University of Sheffield (Registration Number 011338) 
 
ePAQ-PF is a web-based instrument, in the form of an electronic questionnaire, which provides a 
detailed assessment of a woman’s pelvic floor symptoms and their impact [9-11]. The 
questionnaire can be completed online, prior to clinic attendance, or using a touch-screen 
computer terminal in a private room in the clinic. Computer interviewing using ePAQ-PF 
provides women with an opportunity to report symptoms of an intimate and sensitive nature, 
which may be difficult to express in a face-to-face consultation [12, 13].  
 
The questionnaire comprises of four dimensions (areas of the questionnaire which assess different 
types of symptomatology): Urinary, Bowel, Vaginal and Sexual. Within each dimension are four 
to five scored domains. Domain scores are derived by dividing the sum of all item scores in that 
domain by the total possible item score and multiplying this by 100 to produce a scale ranging 
from 0 (best possible) to 100 (worst possible health status). Data for the present study were used 
anonymously from women who answered ‘Yes’ to the final item of the questionnaire, which seeks 
consent to allow confidential use of their answers for approved research projects. 
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Between January 2012 and September 2015, 2,905 women completed ePAQ-PF as part of their 
routine clinical care, prior to their first consultation in the urogynaeoclogy clinic. Two hundred 
and thirty two women (8%) declined consent for the use of their data for research, and a further 
361 women did not complete the consent question. Therefore, data from 2,312 women were 
anonymised and transferred to SPSS (version 22) for analysis. 
 
Table 1 shows the ePAQ-PF items included in the analyses of this study. Response options for all 
these items are on a four-point scale ‘Never’, ‘Occasionally’, ‘Most of the time’ or ‘All of the 
time’ and scored 0, 1, 2 or 3 respectively. The impact attributed to each of these symptoms is also 
recorded, using a standard sub-question ‘How much of a problem is this for you?’ and graded as 
‘Not a problem’, ‘A bit of a problem’, ‘Quite a problem’ or ‘A serious problem’ and scored 0, 1, 
2 and 3 respectively. Frequency and bothersomeness are thereby assessed for each symptom. 
Figure 1 shows the ePAQ-PF item relating to coital incontinence. The domain score for OAB is 
derived from items 21 to 24 and that for SUI from items 28-32 (Table 1).  
Both Spearman’s rank and logistic regression were used to measure the association between 
coital incontinence symptoms (items Q101, Q102 and Q103) with symptoms of OAB and SUI 
(items Q21-32). Mann-Whitney Test was used to compare self-avoidance of sex, (Q98) partner-
avoidance of sex (Q99) and interference of sex with enjoyment of life (Q122) in women with and 
without CI. 
 
ePAQ-PF also includes a free-text question which asks: ‘Considering the issues that currently 
concern you the most, what do you hope to achieve from any help, advice or treatment?’. All free 
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text responses were reviewed to evaluate self-reporting of sexual concerns and goals, including 
free-text responses specifically related to coital incontinence.  
  
Subgroup analysis was undertaken in 84 women who underwent tension-free vaginal tape (TVT) 
procedure, in order to evaluate whether treatment of SUI is associated with changes in coital 
incontinence. Data from consenting patients who underwent TVT between 2012 and 2015 and 
completed ePAQ-PF both pre- and three-months post operatively were included in the study. All 
women reported stress urinary incontinence and underwent urodynamics in line with ICS 
guidelines [14]. It is the usual practice at Sheffield Teaching Hospitals to complete urodynamic 
studies before undertaking surgery for stress urinary incontinence. Paired Student t Test was used 
to compare the pre- and post-operative OAB and SUI domain scores in women reporting coital 
incontinence pre-operatively. Wilcoxon signed ranks test was used to compare pre- and post-
operative symptoms of CI.   
Demographic details for consenting patients undergoing TVT were collected from the 
standardised anaesthetic pre-operative assessment and include body mass index (BMI), smoking 
status, hypertension, sleep apnoea, depression or anxiety, diabetes and American Society of 
Anesthesiologists (ASA) grade. Demographic data and co-morbidities were compared between 
patients reporting pre-operative coital incontinence and those who did not. BMI was compared 
using student t test. The proportion of hypertension, smoking, diabetes, sleep apnoea, depression 
and anxiety in patients reporting coital incontinence and those who did not was compared with 
Pearson Chi-Square and Fisher’s Exact tests, depending on the prevalence of the co-morbidities. 
ASA scores were compared using the Mann-Whitney U test. The reasons for the four different 
statistical tests for demographic features, were the different data types: BMI was of continuous 
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data type, (student T test), ASA score was of ordinal data type (Mann-Whitney U test) and co-
morbidity and smoking status of categorical data type (Pearson Chi-Square test or Fisher Exact 
test, depending the prevalence of each item). 
Results 
Prevalence of coital incontinence 
Between January 2012 and September 2015, 2,312 women completed ePAQ-PF and gave 
consent for the use of their data. Of these, 1,573 completed Q101 regarding coital incontinence, of 
whom 477 (30.3%) reported the presence of this symptom.  The overall prevalence of coital 
incontinence was 21% (477 of 2,312). The question on orgasm coital incontinence was answered 
by 1,533 women, of whom 369 (24.1%) reported the presence of this symptom (16% overall). 
The question of penetration coital incontinence was answered by 1,532 women, of whom 230 
(15.0%) reported the presence of this symptom (10% overall).  
The item on urinary incontinence was answered by 2,294 women, of whom 1,438 reported this 
symptom. Amongst those women reporting urinary incontinence, 946 answered the question on 
coital incontinence, of whom 451 (47.7%) reported the presence of the symptom. Of the women 
without urinary incontinence, 26 reported coital incontinence (1%). 
 
Association between coital incontinence, SUI and OAB scores 
Three binomial logistic regression models were used to explore the relationship between SUI and 
OAB symptoms with coital incontinence, orgasm incontinence and penetration incontinence. 
Symptoms of OAB (p<0.005) and SUI (p<0.005) were shown to be significant and independent 
predictors of coital incontinence.  
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Increasing OAB domain scores were associated with increasing odds of coital incontinence 
(OR=1.042 95%CI, 1.035 to 1.050, p <0.0005), orgasm incontinence (OR=1.035 95%CI, 1.028 
to 1.042, p <0.001) and penetration incontinence (OR=1.038 95%CI, 1.030 to 1.045, p <0.001). 
Increasing SUI domain scores were associated with increasing odds of coital incontinence 
(OR=1.017 95%CI, 1.009 to 1.024, p <0.0005), orgasm incontinence (OR=1.011 95%CI, 1.004 
to 1.019, p =0.003) and penetration incontinence (OR=1.024 95%CI, 1.015 to 1.033, p <0.001). 
These data are all statistically significant, but the magnitude of the effect is relatively low, 
possibly due to the large sample size. 
 
Spearman’s Rank Order Correlation showed similar results of moderate statistically significant 
association between coital incontinence symptom score with both SUI (Rs=0.410, p<0.001) and 
OAB (Rs=0.540, p<0.001); orgasm incontinence with SUI (Rs=0.339, p<0.001) and OAB 
(Rs=0.462, p<0.001); penetration incontinence with SUI (Rs=0.361, p<0.001) and OAB 
(Rs=0.443, p<0.001). These results are displayed as product plots in figure 2.  
 
Coital incontinence with impact on sex 
Mann-Whitney Test was used to compare reported self-avoidance of sex due to bladder 
problems, partner-avoidance of sex due to bladder problems and overall interference of sex with 
enjoyment of life and the impact of each of these in women who reported coital incontinence 
compared with those who did not. This showed significant self-avoidance of sex (p<0.0005), 
partner avoidance of sex (p<0.0005) and lower quality of life due to sexual problems (p<0.0005), 




Pre-operative symptom profiles in women undergoing TVT 
Pre and post operative ePAQ-PF data were available for 84 women who gave consent for the use 
of their data. Coital incontinence was reported by 45 (54%). Table 3 shows a comparison of pre-
operative symptom profiles between women with and without coital incontinence. 
This analysis found that women reporting coital incontinence were significantly younger than 
those who did not (Mean age 48 vs. 55) (t(67)= 3.448, p= 0.001). The BMI of women reporting 
orgasm incontinence (t(56)= -2.750, p=0.008) and penetration  incontinence (t(57)= -3.205, 
p=0.002) was significantly higher than that of patients without coital incontinence.  
 
TVT outcome 
Paired t test was used to compare pre-operative and post-operative OAB and SUI domain scores 
in all 84 women undergoing TVT and found significant improvement in all the symptoms 
analysed (Table 4). Wilcoxon signed rank test was used to conduct sub-group analysis in the 45 
women undergoing TVT who reported coital incontinence  pre-operatively (55%).  This found 
significant improvement in the reporting of any coital incontinence, orgasm incontinence and 
penetration incontinence following TVT (table 5). Of the 45 patients with coital incontinence, 37 
completed follow up at three months. Of these, 27 (72%) had improved nine (20%) reported no 
change and one (3%) worsened (p<0.001).  
The association between cure of SUI following TVT and the presence of pre-operative coital 
incontinence (coital incontinence, orgasm incontinence and penetration incontinence) was 
analysed using Pearson Chi-Square test and Fisher’s Exact test. The presence of coital 
incontinence  pre-operatively was not associated with the outcome in terms of SUI (X2= 1.001, 
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p=0.317); neither was pre-TVT orgasm incontinence status (X2= 2.745, p=0.098) or pre-TVT 





The free-text item relating to ‘Greatest concerns’ was completed by 1,261 women (55%), 24 of 
whom used free-text to report concerns regarding sexual function (1%). Four women explicitly 
reported coital incontinence, five said that they wanted to improve or resolve problems in their 
sex life, but did not detail the specific problem. Three women reported reduced sensation during 




The primary objective of this study was to investigate the prevalence of coital incontinence and 
its association with SUI, OAB and sexual function in women attending a urogynaecology clinic. 
 
The main findings are that coital incontinence is reported by approximately one in five women 
attending urogynaecology clinics and is associated with avoidance of sexual activity. Coital 
incontinence is associated with both SUI and OAB, regardless of whether this occurs at orgasm 
or on penetration. Following TVT, 60% of women reported cure in coital incontinence. 
 
The main weakness of this study is its observational nature and that data on other aspects of 
sexual function, sexuality and relationship status were not available. We are therefore unable to 
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comment on other factors which may affect sexual function and coital incontinence; including 
menopausal status and other physical and mental health issues. Detailed demographic data for 
the 2312 women are also lacking, including parity and ethnicity. 
 
This is however the largest study to-date relating to coital incontinence in women attending a 
urogynaecology clinic, which has found a prevalence of 21% overall, 30% in women willing to 
answer questions about sexual function and 47% in women reporting urinary incontinence. The 
results are comparable to a previous study in an earlier cohort of women in our unit, which found 
a coital incontinence prevalence of 60% in women undergoing urodynamic studies for urinary 
incontinence [5]. 
 
Previous studies have shown rates of coital incontinence in women attending urogynaeoclogy 
clinics of up to 24%[2, 4] If the prevalence of coital incontinence is assessed only in women with 
urinary incontinence the rates have been shown to vary between 10% - 66% 
[5][6][15][16][17][18].  
Including this study, three studies have assessed coital incontinence in women attending a 
urogynaecology clinic. The prevalence was 10% [15] when direct questioning was used to assess 
prevalence and 36% [6] and 47% when a validated questionnaire (KHQ or ePAQ-PF) was used. 
Four studies assessed the prevalence of coital incontinence in women undergoing urodynamics. 
Two of these studies used direct questioning to assess this and both found a prevalence of 11% 
[8][18]. The other two studies used validated (ePAQ-PF) or non-validated (author’s own) 
questionnaires to assess prevalence and found it to be 60% [5] and 66% [17] respectively. The 
substantially higher prevalence of coital incontinence in women undergoing urodynamics, 
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compared with women attending a urogynaecology clinic, is likely to be a reflection of more 
severe symptoms in women undergoing urodynamics.  
It is apparent that using a questionnaire, substantially increases disclosure and therefore the 
reported prevalence of coital incontinence, compared with direct questioning. This may be due to 
embarrassment and the taboo nature of this intimate problem.  
 
Using ePAQ-PF to assess coital incontinence has the advantage of specifically enquiring about 
urinary coital incontinence and when it occurs- with orgasm or penetration. Other questionnaires 
used widely within urogynaecology do not assess coital incontinence as comprehensively. The 
Pelvic organ prolapse urinary Incontinence Sexual Questionnaire (PISQ) doesn’t differentiate 
between faecal and urinary incontinence during intercourse and doesn’t assess if the incontinence 
occurs with orgasm or penetration, the International Consultation on Incontinence modular 
Questionnaire- Short Form (ICIQ-SF) does not ask about coital incontinence or sexual issues at 
all and the Kings Health Questionnaire (KHQ), whilst it does assess the prevalence of coital 
urinary incontinence, doesn’t distinguish between orgasm incontinence and penetration 
incontinence. 
 
We found that orgasm coital incontinence was significantly associated with the reporting of both 
symptoms of both SUI and OAB. Likewise, penetration incontinence was also significantly 
associated with symptoms of both SUI and OAB. Studies have previously linked orgasm 
incontinence to OAB, demonstrating higher rates of detrusor overactivity during urodynamics in 
women with orgasm incontinence than in women with penetration incontinence [2, 7, 18]. 
Penetration incontinence has similarly been linked to stress urinary incontinence [15, 17]. 
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However, larger and more recent studies have found no significant relationship between 
urodynamic diagnosis and penetration or orgasm incontinence [5]. It has also been shown that 
both Urodynamic Stress Incontinence (USI) and Detrusor overactivity (DO), but not DO 
incontinence, are both significantly associated with coital incontinence [8]. As seen in table four, 
both orgasm incontinence and penetration incontinence were significantly improved following 
TVT, suggesting a similar aetiology for coital incontinence in women with these symptoms. 
  
There is a significant overlap between women who have coital incontinence at penetration and 
coital incontinence at orgasm, with 26% of women in our study group reporting both symptoms. 
Therefore, attempting to separate orgasm and penetration coital incontinence into different 
diagnostic groups may not be helpful or meaningful; many women have elements of both and the 
symptoms may not be indicative of distinct pathophysiological entities.  
A previous anatomical study used MRI to measure the pubococcygeal line, hiatal width and 
levator descent to assess pelvic organ prolapse in 60 women with coital incontinence, compared 
with a control group of 30 women with urinary incontinence but no coital incontinence. No MRI 
features were identified that were significantly associated with coital incontinence in that 
study[17]. Proposed mechanisms for coital incontinence include increased abdominal pressure 
during intercourse, which may vary depending on position; increased abdominal pressure due to 
contraction of abdominal muscles during orgasm and straightening of the urethra during deep 
penetration [19]. The precise mechanism is however not fully understood.  
 
Urinary incontinence is well known to cause sexual dysfunction [20-22]. It is clear from the 
present study that women with coital incontinence commonly avoid sex, their partners 
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commonly avoid sex with them and they have a significantly impaired sexual function compared 
with women without coital incontinence. In a study of 633 women with urinary incontinence, 
assessed using the King’s Health Questionnaire (KHQ), women with coital incontinence were 
observed to have significantly worse scores in all KHQ dimensions and global score [6]. A 
logistic regression model in the study found that the only variable which demonstrated 
independent association with the KHQ global score was coital incontinence (B=10.1, 95% 
CI=1.7-18.5). A further study of 180 women using the Bristol Female Lower Urinary Tract 
Symptoms questionnaire and the Medical Outcomes Study Short Form (SF-36) questionnaire 
observed that women with coital incontinence had more health-related quality of life impairment 
than those without coital incontinence [23]. A qualitative study of 37 women scheduled for 
pelvic floor surgery using semi-structured interviews found that nine of the 37 women had 
experienced coital incontinence [24]. These women tried to avoid coital incontinence by 
emptying their bladders before intercourse and also avoided certain sexual positions, hurried 
through sex so that it would be over quicker, avoided orgasm and did self-directed pelvic floor 
muscle training. These measures were reportedly successful in four of the nine patients.  
 
It is clear that coital incontinence causes embarrassment to women [25] and leads to avoidance 
of sex which in turn affects quality of life. Previous studies addressing the prevalence of coital 
incontinence  and its associations have shown that coital incontinence  is a rarely volunteered 
symptom. Only two of 400 women in Hilton’s study paper [2] and one of 100 in Gordon’s study 
[4] volunteered that they had coital incontinence prior to questioning. Urinary symptoms may be 
the presenting complaint in women who have an underlying sexual problem [25], it is therefore 
important to routinely enquire about coital incontinence in women attending the urogynaecology 
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clinic. In our study, of 2,312 women completing ePAQ-PF, only 1% used the free-text items to 
report a sexual problem, and only four recorded that they had coital incontinence using free text. 
It is also clear from the differing prevalence rates of coital incontinence  in women with urinary 
incontinence observed in previous studies that using an appropriate questionnaire will help 
identify women experiencing this symptom. There is evidence that patients may feel more 
comfortable disclosing embarrassing or intimate issues through use of a computer questionnaire 
than during a conventional consultation [26]. By using a validated questionnaire to identify 
women experiencing coital incontinence, a more open and honest consultation can be afforded 
and more appropriate treatment planned. It has been shown that electronic questionnaires can 
increase discussion rates in women with urinary incontinence [8] and seems likely that this is 
also the case for coital incontinence.  
 
Our study found significant improvement in SUI and OAB at three months follow-up in women 
undergoing TVT. There was also a statistically significant improvement in coital incontinence at 
penetration, orgasm and overall. Coital incontinence was not shown to be a predictor for poorer 
outcome at TVT in this study. 
In previous studies, TVT has been shown to improve sexual function.  In 2007 Jha et al reported 
improved sexual function at six months post-operatively in 54 women assessed using PISQ-12 
[27]. The study showed that coital incontinence was significantly reduced after TVT, with 38 
women being affected pre- and 15 post-operatively (p<0.002). In 2009 Bekker et al showed that 
women with coital incontinence show a significantly higher improvement in sexual function at 
three to twelve months post-op (61 TVT, 32 TVT-O and 43 TOT), compared with those without 
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coital incontinence [16]. The authors concluded that coital incontinence is a prognostic factor for 
improvement in sexual function after incontinence surgery.  
Glavind et al in 2014 observed that in 51 women undergoing TVT, sexual function significantly 
improved and coital incontinence  assessed by PISQ-12 was significantly reduced (p<0.005) at 
six months post-operatively [28]. The same authors subsequently published a follow-up study in 
this group, with 44 patients followed up at both at six months post TVT and again at a mean of 
four years and nine months [29], showing that sexual function and coital incontinence  remained 
significantly improved at long-term follow-up, with no significant differences between six month 
and long term follow up. 
In a previous study, Serati et al used antimuscarinics (tolteridine 4mg) to treat women with coital 
incontinence at orgasm, and observed inferiority in the treatment of OAB, compared with 
women without orgasm CI, supporting the view that incontinence at orgasm is either a marker of 
more severe detrusor overactivity or that it is more of a marker for SUI [18]. The improvement in 
coital incontinence post TVT lends support to this latter theory.  
 
The demographics of the patients with coital incontinence in our study group undergoing TVT 
showed that younger age was a significant co-factor for coital incontinence, which is likely to be 
related to higher levels of sexual activity in this age group. Raised BMI was also a risk factor for 
both penetration and orgasm coital incontinence. This was also demonstrated in the study by 
Madhu et al [8], which also observed a significant association between coital incontinence and 
cigarette smoking and antidepressant use. High BMI is an established risk factor for urinary 
incontinence [30] and this is thought to be due to increased intra-abdominal pressure and 
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increased stress on the pelvic floor. This again points towards a stress related mechanism rather 
than a detrusor over activity mechanism for coital incontinence. 
 
In conclusion, the present study has found coital incontinence  to be highly prevalent and affects 
more than half of women with urinary incontinence. It is also a rarely volunteered symptom and 
even on direct questioning, women may not admit to coital incontinence. The value of 
questionnaires to help in the assessment of women in this context cannot be underestimated. 
Coital incontinence has a significant negative impact on sexual function and results in avoidance 
by both partners. Both coital incontinence at orgasm and penetration are significantly associated 
with both SUI and OAB. and should not be considered completely separate entities.  TVT results 
in a significant improvement in coital incontinence symptoms and improves sexual function for 
women with SUI. Further studies, including multiple centres using ePAQ-PF, are needed to 
confirm and develop these findings. Further research into the precise mechanisms of coital 
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• Q23 Does urine leak when you wash your hands or hear the sound of running water? 
• Q24 Does urine leak when you are opening or unlocking your door to your home? 
• Q28 Does urine leak when you cough? 
• Q29 Does urine leak when you sneeze? 
• Q30 Does urine leak when you exercise, lift things, jump or run? 
• Q31 Does urine leak with movements such as standing up, bending down or getting dressed? 
• Q32 Does urine leak when you are walking? 
 
Sexual dimension 
• Q98 Do you avoid sexual activity because of your bladder or urinary problems? 
• Q99 Do you feel that your partner avoids sexual activity with you because of your bladder or urinary 
problems? 
• Q101 Does urine leak when you have sexual intercourse? 
• Q102 Do you leak urine when you have an orgasm? 
• Q103 Does urine leak at the start of sexual intercourse? 
(i.e. on penetration) 





The frequency and impact of coital incontinence on self-avoidance and partner avoidance of sex 
and interference with enjoyment of life. 
 
 





Self-avoidance 365.74 586.34 p <0.0005 
Impact of self-
avoidance 
356.22 596.77 p <0.0005 
Partner-avoidance 411.92 515.84 p <0.0005 
Impact of partner-
avoidance 
407.53 520.74 p <0.0005 
Overall enjoyment of 
life  
338.08 610.44 p <0.0005 
Impact of overall 
enjoyment of life 

















































Age 48.3± 8.0 55.46± 8.8 Student t Test t(67)= 3.448,  
p= 0.001 
BMI 30.4± 5.6 28.0± 5.7 Student t test t(57)= -1.616,  
p= 0.112 













Diabetes 0/36 2/23 Fisher exact 
test 
p=0.516 
Sleep apnoea 5/36 2/23 Fisher exact 
test 
p=0.694 
Depression 5/36 3/23 Fisher exact 
test 
p=1.000 
















Age 49.0± 8.2 52.9± 9.3 Student t 
Test 
t(66)= 1.824,  
p= 0.073 
BMI 31.6± 5.9 27.7± 5.1 Student t 
test 
t(56)= -2.750,  
p= 0.008* 
















Diabetes 1/28 1/30 Fisher 
exact test 
p=1.000 
Sleep apnoea 3/28 3/30 Fisher 
exact test 
p=1.000 
Depression 6/28 3/30 Fisher 
exact test 
p=0.290 
















Age 50.2± 7.7 51.1± 9.6 Student t 
Test 
t(67)= 0.370, p= 
0.0713 


















Diabetes 2/20 0/39 Fisher 
exact test 
p=0.111 
Sleep apnoea 4/20 3/39 Fisher 
exact test 
p=0.213 
Depression 4/20 4/39 Fisher 
exact test 
p=0.424 














Table four: Paired t test was used to compare the pre-operative and post -operative OAB 








OAB Domain of 
ePAQ-PF 
30.59±19.46/100 18.99±19.70/100 t(78)= 5.557,  
p< 0.001 
SUI Domain of 
ePAQ-PF 





Wilcoxon signed ranks test was used to compare the pre-operative and post-operative symptoms 
of coital incontinence, orgasmic coital incontinence and penetrative coital incontinence. It 
























































Figure 2: Product plots showing the correlation between domain scores for stress urinary incontinence 
(SUI) and overactive bladder (OAB) with overall reported coital incontinence, coital incontinence at 
orgasm and that at penetration. The shading of each square displayed varies depending on the number of 
patients reporting the specific frequency of coital incontinence symptoms (never, occasionally, most of 





















condition’	 was	 assessed.	 Pre-	 and	 post-operative	 symptom	 scores	 were	 compared	 using	
repeated	 mixed	 ANOVA	 test	 for	 BMI	 as	 a	 categorical	 variable	 (Normal,	 Overweight	 and	
Obese).	 Spearman’s	 rank	 order	 correlation	 test	 was	 carried	 out	 to	 evaluate	 BMI	 as	 a	




‘Overall	 change	 in	 condition’	 was	 negatively	 correlated	 with	 increasing	 BMI	 (rs=	 -0.324,	
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p=0.028).	 Irrespective	 of	 BMI,	 significant	 improvements	 were	 observed	 in	 symptoms	 of	
prolapse	and	VS-QoL	at	three-months	post	operation.			
Conclusions		
With	 increasing	 BMI,	 women	 are	 likely	 to	 report	 lower	 levels	 of	 satisfaction	 following	
prolapse	surgery,	despite	reporting	equivalent	improvements	in	symptoms.	BMI	is	known	to	
affect	how	individuals	perceive	their	general	health	and	well-being	with	obese	individuals	
reporting	 poorer	 levels	 of	 subjective	 health	 status.	 	 Women	 with	 obesity	 may	 perceive	
change	 in	 their	 condition	 after	 prolapse	 surgery	 differently	 to	women	 of	 normal	weight.		



























appear	 to	 be	 affected	 by	 obesity	 [11-13],	 whereas	 a	 study	 of	 women	 undergoing	















The	 study	 included	 all	 women	 undergoing	 vaginal	 hysterectomy	 at	 Sheffield	 Teaching	
Hospitals	NHS	Foundation	Trust,	UK,	 during	 the	 three	 year	 study	period	who	 completed	
ePAQ-PF	pre-operatively	and	three	months	post-operatively,	with	documented	Body	Mass	
Index	(BMI)	and	patient	consent	for	their	data	to	be	used	for	research.		
















































technique.	 All	 women	 undergoing	 vaginal	 hysterectomy	 and	 vaginal	 wall	 repair	 had	 a	
procedure	using	absorbable	suture	materials	only.	No	mesh	inlays	or	non-absorbable	suture	
materials	were	used	as	part	of	 surgery.	All	women	had	Mc’Call’s	 culdoplasty	 to	unite	 the	
uterosacral	 ligaments	 in	 the	 midline	 and	 obliterate	 the	 deadspace	 where	 a	 potential	











































The	 pre-operative	 impact	 of	 prolapse	 on	 vaginal	 symptoms	 quality	 of	 life	 (VS-QoL)	was	






Forty-six	women	 (77%)	 answered	 the	 global	 rating	 of	 outcome	 question,	 of	whom	 93%	
(n=43/46)	reported	 improvement	 in	 their	condition.	 	One	woman	 felt	 that	 there	was	 ‘No	
change’	and	two	women	felt	 that	 their	condition	was	 ‘A	 little	worse’.	 	Surgery	resulted	 in	
improvement	in	overall	condition	in	all	groups:	normal	weight	group	(4.9	±	0.3),	overweight	
group	(4.6	±	0.9)	and	obese	group	(4.5	±	0.8).		Analysing	BMI	as	a	continuous	variable,	BMI	




Significant	 improvement	 was	 seen	 in	 the	 prolapse	 symptoms	 domain	 score	 for	 all	 BMI	
groups	(Table	3).		Data	from	all	patients	combined	(n=60)	showed	91%	improvement,	from	
55	 ±	 18	 to	 6	 ±	 14	 (p<0.0005).	 	 There	 was	 no	 significant	 difference	 in	 the	 degree	 of	
improvement	 of	 prolapse	 symptoms	 with	 increasing	 BMI	 (repeated	 mixed	 ANOVA	 test,	
p=0.57,	 Spearman’s	 rank-order	 correlation	 test	 (rs=-0.104,	 p=0.44)).	 	 There	 was	 no	
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The	 two	most	 commonly	 reported	 symptoms	of	 prolapse	were	 ‘Awareness	 of	 something	
coming	down’	and	‘Awareness	of	a	lump’,	reported	by	97%	and	95%	of	women	respectively.		
‘Vaginal	laxity’	was	reported	by	48%	of	women.		Data	from	all	patients	combined	showed	













which	 leads	 to	 associated	 pressure	 on	 the	 pelvic	 floor	 is	 the	 theoretical	 mechanism	






Health	 Initiative	 (WHI)	 trial,	which	 investigated	health	 issues	 in	women	 taking	hormone	
replacement	therapy;	16,608	women	were	followed	up	over	a	five-year	period	to	investigate	







lost	 5-10%	 of	 their	 body	 weight	 were	 significantly	 more	 likely	 to	 achieve	 substantial	















colporrhaphy	 [27].	 	 Conversely,	 a	 five-year	 prospective	 study	 of	 376	women	undergoing	
prolapse	and	 incontinence	 surgery	 found	no	association	between	obesity	and	 recurrence	













Since	 increasing	 BMI	 was	 associated	 with	 a	 lesser	 degree	 of	 overall	 improvement	 in	
condition	and	improvement	in	POP	symptoms	was	not	related	to	BMI,	perception	of	outcome	
may	be	related	to	factors	other	than	impact	of	prolapse	surgery	on	prolapse	symptoms.		Body	




health	 status	 [31].	 	 A	 population	 survey	 of	 2000	 people	 in	 America	 reported	 decreased	
HRQoL	with	increasing	obesity,	even	without	the	presence	of	chronic	disease	[31],	and	in	a	
population	 survey	 of	 almost	 10000	 people	 in	 Australia	 who	 completed	 the	 Short	 Form	
Health	Survey	(SF-36),	high	BMI	was	associated	with	reduced	levels	of	physical	and	mental	







life	 (VS-QoL)	 pre-operatively	 than	 normal	 weight	 or	 overweight	 patients,	 a	 possible	
explanation	for	this	being	a	relationship	between	physical	activity	and	BMI.	 	Women	with	
obesity	may	be	less	likely	to	engage	in	physical	activity	than	women	of	normal	weight	and	
therefore	 report	 less	 impact	 of	 prolapse	 on	 their	 quality	 of	 life.	 	 This	 finding	may	 relate	














In	 conclusion,	we	suggest	 that	with	 increasing	BMI,	women	are	 likely	 to	be	satisfied	 to	a	
lesser	degree	with	the	outcome	of	prolapse	surgery.		This	may	have	important	implications	
in	pre-operative	counselling	and	management	of	patients.		Future	studies	should	investigate	
the	 impact	 of	 obesity	 on	 outcomes	 of	 surgery	 for	 anterior	 and	 posterior	 compartment	
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	 BMI	 Age	 Parity	 Surgical	procedure	
	 21.5	 37	 2	 VH	+	AR	
	 22.4	 83	 3	 VH	+	AR	
	 23.3	 62	 2	 VH	+	AR	+	SSF	
	 24.2	 58	 3	 VH	+	AR	
	 24.2	 73	 3	 VH	+	AR	
	 24.3	 67	 2	 VH	+	AR	+PR	
	 21.2	 63	 2	 VH	+	AR	
	 23.5	 64	 3	 VH	+	AR	
	 21.2	 55	 2	 VH	+	PR	+	SSF	
	 22.5	 49	 2	 VH	+	AR	
	 18.5	 63	 1	 VH	+	AR	
	 21.2	 65	 2	 VH	+	AR	+	PR	
	 20.6	 66	 2	 VH	+	AR=	PR	
	 21.2	 72	 2	 VH	+	AR	
	 24.3	 63	 3	 VH	+	AR+	PR	
	 23.5	 61	 4	 VH	+	AR	
	 24.7	 56	 3	 VH	+	AR	
	 24.1	 62	 2	 VH	+	AR	+	PR	
	 24.2	 60	 1	 VH	+	AR	
	 21.8	 85	 4	 VH+	PR	




	 BMI	 Age	 Parity	 Surgical	procedure	
	 25.8	 62	 3	 VH	+	AR	
	 27.7	 48	 5	 VH	+	AR	
	 26.6	 52	 4	 VH	+	AR	
	 27.5	 56	 3	 VH	+	AR+	PR	
	 28.3	 67	 2	 VH	+	AR	
	 28.3	 68	 2	 VH	+	AR	
	 29.7	 63	 2	 VH	+	AR+	PR	
	 26.7	 68	 2	 VH	+	AR	
	 25.6	 58	 3	 VH	+	AR	
	 28.2	 56	 2	 VH	+	AR	
	 27.6	 57	 2	 VH	+	AR+	PR	
	 29.6	 63	 1	 VH	+	AR	+	PR	
	 27.5	 65	 2	 VH	+	AR	
	 28.4	 68	 2	 VH	+	PR+	SSF	
	 26.3	 60	 2	 VH	
	 29.7	 67	 3	 VH	+	AR	
	 26.6	 64	 3	 VH	+	AR+	PR	
	 28.5	 45	 1	 VH	+	AR	
	 26.2	 49	 2	 VH	+	AR	
	 28.6	 84	 4	 VH	+	AR	+PR	
AVERAGE	 27.67	 61	 2.5	 	 	
Obese	group	(BMI	30-35)	 	
	 BMI	 Age	 Parity	 Surgical	procedure	
	 30.6	 82	 2	 VH	+	AR	
	 33.7	 76	 3	 VH	+	AR	
	 34.9	 53	 2	 VH	+	AR+	PR+	SSF	
	 35.0	 62	 3	 VH	+	AR	
	 33.8	 67	 3	 VH	+	AR	+	PR	
	 32.1	 68	 2	 VH		
	 31.2	 49	 2	 VH	+	AR	
	 33.2	 62	 3	 VH	+	AR+	PR	
	 31.5	 73	 2	 VH	+	AR	+	PR	
	 33.8	 54	 2	 VH	+	AR	
	 34.3	 73	 1	 VH	+	AR	
	 34.9	 53	 2	 VH	+	AR	
	 33.5	 76	 2	 VH	
	 32.7	 42	 2	 VH	+	AR	
	 32.8	 50	 3	 VH	+	PR	
	 33.8	 64	 4	 VH	+	AR	
	 32.1	 74	 3	 VH	+	AR	
	 34.8	 63	 2	 VH	+	AR		
	 33.8	 67	 1	 VH	+	AR	+	PR	
	 34.7	 88	 3	 VH	+	PR	

















20	 57	±	27	 10	±	24	 47	±	39	 82%	 (p<0.0005)	
Overweight	 20	 57	±	26	 10	±	22	 47	±	34	 82%	 (p<0.0005)	
























20	 60	±	16	 6	±	18	 54	±	25	 90%	 (p<0.0005)	
Overweight	
	
20	 55	±	16	 5	±	13	 50	±	22	 91%	 (p<0.0005)	






















2	±	0.7	 0.3	±	0.7	 1.9	±	0.9		 95%	 (p<0.0005)	















































































































































assess	 both	 the	 frequency	 and	 impact	 of	 pelvic	 floor	 symptoms	 across	 four	 dimensions:	











The	 electronic	 instrument	 automatically	 generates	 scores	 across	 19	 validated	 domains,	









































































































































































etc.),	 but	 also	 details	 that	 have	 been	 learned	 about	 themselves,	 either	 from	 personal	
experiences	or	by	internalising	the	judgments	of	others	[18].	The	term	Genital	self-image	has	
also	been	used	to	describe	the	mental	picture	that	an	individual	has	of	his	or	her	external	







covered	 by	 the	 quantitative	 components	 of	 the	 questionnaire	 [6].	 	 Currently	 there	 is	 no	
specific	instrument	available	which	assesses	body	image	exclusively	in	women	with	pelvic	
floor	 conditions.	 The	 definition	 of	 the	 female	 genitalia	 does	 not	 necessarily	 include	 the	
perineum,	vagina	and	perianal	region,	which	are	often	involved	in	pelvic	floor	conditions,	
including	 incontinence	 and	 pelvic	 organ	 prolapse.	 Therefore,	 a	 broader	 definition	 than	

































































































































































































































































































68	 23.1±41.7	 41.7±39.2	 <0.005	 0	 3	 <0.005	
Voiding 
dysfunction 1212	
53	 16.6±38.3	 38.1±47.4	 <0.005	 0	 2	 <0.005	
Urinary pain 
and sensation 1213	
52	 12.3±33.4	 24.4±45.1	 <0.005	 0	 2	 <0.005	
QoL Urinary 
1132	
133	 33.0±66.12	 66.3±59.0	 <0.005	 -	 -	 	
Bowel	dimension	
Constipation 1206	 59	 21.2±40.7	 53.0±52.9	 <0.005	 0	 2	 <0.005	
Irritable 
Bowel 1237	
28	 27.7±41.9	 46.2±46.1	 <0.005	 0	 2	 <0.005	
Bowel 
evacuation 1194	
71	 20.8±38.2	 47.1±42.3	 <0.005	 0	 3	 <0.005	
Bowel 
continence 1163	
102	 16.3±33.0	 38.4±39.4	 <0.005	 0	 3	 <0.005	
QoL Bowel 1235	 30	 22.6±60.0	 53.7±71.5	 <0.005	 -	 -	 	
Vaginal	dimension	
Prolapse 857	 408	 16.5±45.4	 54.6±52.0	 <0.005	 0	 2	 <0.005	
Vaginal pain 
and sensation 1078	
187	 19.1±39.4	 33.1±43.0	 <0.005	 0	 2	 <0.005	
Vaginal 
capacity 1254	
11	 9.0±41.3	 34.3±61.1	 0.021	 0	 1	 <0.005	





23	 25.7±63.4	 47.6±53.16	 <0.005	 0	 3	 <0.005	
Sex & bowel 
symptoms 1260	
5	 15.2±53.09	 36.6±19.2	 0.072	 0	 2	 0.001	
Sex & vaginal 
symptoms 1223	
42	 36.2±69.0	 64.4±46.6	 <0.005	 0	 3	 <0.005	
Dyspareunia 1189	 76	 23.3±49.7	 41.4±44.75	 <0.005	 0	 3	 <0.005	
General sex 
life QoL 1217	





















































































and	 in	 different	 settings,	 including	 tests	 of	 stability,	 tests	 of	 data	 quality,	 sensitivity	 and	
responsiveness	 to	 change.	Once	 these	psychometric	properties	of	 ePAQ-Vulva	and	ePAQ-












Likewise,	 the	work	undertaken	 in	paper	one	of	 this	narrative	 thesis	has	 led	 to	 testing	of	
ePAQ-Pelvic	 Floor	 in	 postnatal	women,	 in	 order	 to	 identify	 pelvic	 floor	 symptomatology	
including	 anal	 incontinence.	 Using	 an	 ePROM	 in	 this	 context	 is	 a	 novel	 concept	 and	 the	
ethically	approved	eQuiPP	study	(Electronic	Questionnaires	in	the	Postpartum	Period)	will	
help	to	investigate	and	test	this.	The	evidence	presented	in	paper	1	and	paper	5	regarding	





It	 is	 essential	 that	 high	 quality	 research	 evaluating	 the	 use	 of	 ePROMs	 in	 gynaecology	
continues,	particularly	work	which	examines	the	financial	and	costing	benefits	of	using	such	




high	 quality	 research	 both	 for	 ePROM	 development,	 including	 systematic	 reviews	 of	
psychometric	properties	of	existing	measures	as	well	as	psychometric	testing	of	new	tools,	
and	research	using	data	from	ePROMs	will	similarly	increase.	The	body	of	work	presented	






















01/07/2019, 19:28Rightslink® by Copyright Clearance Center
Page 1 of 2https://s100.copyright.com/AppDispatchServlet
Title: A systematic review of non-
invasive modalities used to
identify women with anal
incontinence symptoms after
childbirth
Author: Thomas G. Gray, Holly Vickers,




Date: Jan 1, 2018
Copyright © 2018, The International Urogynecological
Association
  Logged in as:
  Thomas Gray
 
Order Completed
Thank you for your order.
This Agreement between Dr. Thomas Gray ("You") and Springer Nature ("Springer Nature") consists of
your license details and the terms and conditions provided by Springer Nature and Copyright Clearance
Center.
Your confirmation email will contain your order number for future reference.
printable details
License Number 4620340658261   
License date Jul 01, 2019   
Licensed Content
Publisher
Springer Nature   
Licensed Content
Publication
International Urogynecology Journal   





Thomas G. Gray, Holly Vickers, Swati Jha et al   
Licensed Content Date Jan 1, 2018   
Licensed Content
Volume
30   
Licensed Content Issue 6   
Type of Use Thesis/Dissertation   
Requestor type academic/university or research institute   
Format print   
Portion full article/chapter   
Will you be translating? no   
Circulation/distribution <501   
Author of this Springer
Nature content
yes   
Title Subspecialty Trainee in Urogynaecology   
Institution name Sheffield Teaching Hospitals NHS Foundation Trust   
Expected presentation
date




01/07/2019, 19:28Rightslink® by Copyright Clearance Center
Page 2 of 2https://s100.copyright.com/AppDispatchServlet
Order reference number 2   





Attn: Dr. Thomas Gray
  
Total 0.00 GBP   
 ORDER MORE CLOSE WINDOW
 
Copyright © 2019 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions. 




01/07/2019, 19:33Rightslink® by Copyright Clearance Center
Page 1 of 2https://s100.copyright.com/AppDispatchServlet
Title: Patient-reported outcome
measures which assess body
image in urogynaecology
patients: a systematic review
Author: Thomas G. Gray, Rosanna




Date: Jan 1, 2019
Copyright © 2019, The International Urogynecological
Association
  Logged in as:
  Thomas Gray
 
Order Completed
Thank you for your order.
This Agreement between Dr. Thomas Gray ("You") and Springer Nature ("Springer Nature") consists of
your license details and the terms and conditions provided by Springer Nature and Copyright Clearance
Center.
Your confirmation email will contain your order number for future reference.
printable details
License Number 4620340925022   
License date Jul 01, 2019   
Licensed Content
Publisher
Springer Nature   
Licensed Content
Publication
International Urogynecology Journal   





Thomas G. Gray, Rosanna Sneyd, Kaia Scurr et al   
Licensed Content Date Jan 1, 2019   
Licensed Content
Volume
30   
Licensed Content Issue 5   
Type of Use Thesis/Dissertation   
Requestor type academic/university or research institute   
Format print and electronic   
Portion full article/chapter   
Will you be translating? no   
Circulation/distribution <501   
Author of this Springer
Nature content
yes   
Title Subspecialty Trainee in Urogynaecology   
Institution name Sheffield Teaching Hospitals NHS Foundation Trust   
Expected presentation
date
Jul 2019   




01/07/2019, 19:33Rightslink® by Copyright Clearance Center
Page 2 of 2https://s100.copyright.com/AppDispatchServlet





Attn: Dr. Thomas Gray
  
Total 0.00 GBP   
 ORDER MORE CLOSE WINDOW
 
Copyright © 2019 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions. 































01/07/2019, 19:26Rightslink® by Copyright Clearance Center
Page 1 of 2https://s100.copyright.com/AppDispatchServlet
Title: Evaluation of coital incontinence
by electronic questionnaire:
prevalence, associations and
outcomes in women attending a
urogynaecology clinic
Author: Thomas Gray, Weiguang Li,




Date: Jan 1, 2017
Copyright © 2017, The International Urogynecological
Association
  Logged in as:
  Thomas Gray
 
Order Completed
Thank you for your order.
This Agreement between Dr. Thomas Gray ("You") and Springer Nature ("Springer Nature") consists of
your license details and the terms and conditions provided by Springer Nature and Copyright Clearance
Center.
Your confirmation email will contain your order number for future reference.
printable details
License Number 4620340303261   
License date Jul 01, 2019   
Licensed Content
Publisher
Springer Nature   
Licensed Content
Publication
International Urogynecology Journal   
Licensed Content Title Evaluation of coital incontinence by electronic questionnaire: prevalence, associations and




Thomas Gray, Weiguang Li, Patrick Campbell et al   
Licensed Content Date Jan 1, 2017   
Licensed Content
Volume
29   
Licensed Content Issue 7   
Type of Use Thesis/Dissertation   
Requestor type academic/university or research institute   
Format print   
Portion full article/chapter   
Will you be translating? no   
Circulation/distribution <501   
Author of this Springer
Nature content
yes   
Title Subspecialty Trainee in Urogynaecology   
Institution name Sheffield Teaching Hospitals NHS Foundation Trust   
Expected presentation
date




01/07/2019, 19:26Rightslink® by Copyright Clearance Center
Page 2 of 2https://s100.copyright.com/AppDispatchServlet
Order reference number 1   





Attn: Dr. Thomas Gray
  
Total 0.00 GBP   
 ORDER MORE CLOSE WINDOW
 
Copyright © 2019 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions. 



















01/07/2019, 19:30Rightslink® by Copyright Clearance Center
Page 1 of 2https://s100.copyright.com/AppDispatchServlet
Title: What are the concerns and goals
of women attending a
urogynaecology clinic? Content
analysis of free-text data from
an electronic pelvic floor
assessment questionnaire
(ePAQ-PF)






Date: Jan 1, 2018
Copyright © 2018, The International Urogynecological
Association
  Logged in as:
  Thomas Gray
 
Order Completed
Thank you for your order.
This Agreement between Dr. Thomas Gray ("You") and Springer Nature ("Springer Nature") consists of
your license details and the terms and conditions provided by Springer Nature and Copyright Clearance
Center.
Your confirmation email will contain your order number for future reference.
printable details
License Number 4620340793826   
License date Jul 01, 2019   
Licensed Content
Publisher
Springer Nature   
Licensed Content
Publication
International Urogynecology Journal   
Licensed Content Title What are the concerns and goals of women attending a urogynaecology clinic? Content analysis




Thomas Gray, Scarlett Strickland, Sarita Pooranawattanakul et al   
Licensed Content Date Jan 1, 2018   
Licensed Content
Volume
30   
Licensed Content Issue 1   
Type of Use Thesis/Dissertation   
Requestor type academic/university or research institute   
Format print   
Portion full article/chapter   
Will you be translating? no   
Circulation/distribution <501   
Author of this Springer
Nature content
yes   
Title Subspecialty Trainee in Urogynaecology   




01/07/2019, 19:30Rightslink® by Copyright Clearance Center
Page 2 of 2https://s100.copyright.com/AppDispatchServlet
Expected presentation
date
Jul 2019   
Order reference number 3   





Attn: Dr. Thomas Gray
  
Total 0.00 GBP   
 ORDER MORE CLOSE WINDOW
 
Copyright © 2019 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions. 






I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 
List of co-authored papers  
1. Gray	T,	Money-Taylor	J,	Li	W,	Farkas	AG,	Campbell	P,	Radley	SC.	What	is	the	effect	of	body	mass	index	on	subjective	
outcome	following	vaginal	hysterectomy	for	prolapse?	International	Neurourology	Journal.	2019;23(2):1-8. 
https://doi.org/10.5213/inj.1938016.008 pISSN 2093-4777 · eISSN 2093-6931 	
	
I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  













I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 





I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  


















I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 
List of co-authored papers : 
Gray	TG,	Sneyd	R,	Scurr	K,	Jones	GL,	Iles	D,	Jha	S,	Radley	SC.	Patient-reported	outcome	measures	which	assess	body	image	in	
urogynaecology	patients:	a	systematic	review.	International	urogynecology	journal.	2019	May	1;30(5):673-81.	
I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  













I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 

















I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  
Name: Georgina Jones 
 












I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.
Thank you for your response and please contact me if there are any questions.
Regards
Thomas Gray
List of co-authored papers :
Gray	TG,	Vickers	H,	Jha	S,	Jones	GL,	Brown	SR,	Radley	SC.	A	systematic	review	of	non-invasive	modalities	used	to	identify	women
with	anal	incontinence	symptoms	after	childbirth.	International	Urogynecology	Journal.	2018	Nov	23:1-1.











I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gynaecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 





I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  



























I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 
List of co-authored papers : 
Gray	TG,	Sneyd	R,	Scurr	K,	Jones	GL,	Iles	D,	Jha	S,	Radley	SC.	Patient-reported	outcome	measures	which	assess	body	image	in	
urogynaecology	patients:	a	systematic	review.	International	urogynecology	journal.	2019	May	1;30(5):673-81.	
I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  






















I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 




I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  






















I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 









https://doi.org/10.5213/inj.1938016.008 pISSN 2093-4777 · eISSN 2093-6931 	
	
I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  
Name: Patrick Campbell 
 
Signed:  














Dear Dr Sneyd, 
I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 
List of co-authored papers : 
Gray TG, Sneyd R, Scurr K, Jones GL, Iles D, Jha S, Radley SC. Patient-reported outcome measures which assess body image in 
urogynaecology patients: a systematic review. International urogynecology journal. 2019 May 1;30(5):673-81. 
I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  












I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 





















https://doi.org/10.5213/inj.1938016.008 pISSN 2093-4777 · eISSN 2093-6931 	
	
I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  
Name: Stephen Radley  
Signed:  
 






I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 










I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  

























I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.
Thank you for your response and please contact me if there are any questions.
Regards
Thomas Gray
List of co-authored papers
1. Gray T, Strickland S, Pooranawattanakul S, Li W, Campbell P, Jones G, Radley S. What are the concerns and goals of women
attending a urogynaecology clinic? Content analysis of free-text data from an electronic pelvic floor assessment questionnaire
(ePAQ-PF). International Urogynecology Journal. 2018 Jun 27:1-9.



















Dear Dr Li,  
I am currently in the process of applying for an MD by publication at the University of Sheffield (on ‘The development and utility of electronic 
patient reported outcome measures in gyanecology’). As a co-author on the papers listed below I would be grateful if you would allow me to 
include these papers in my submission. If you agree to this, could you please sign this document and return to me by email or by post to Dr 
Thomas Gray, Room 15, Level 4 Jessop Wing, Tree Root Walk, Sheffield Teaching Hospitals, S10 2SF.  
Thank you for your response and please contact me if there are any questions.  
Regards  
Thomas Gray 
List of co-authored papers  
1. Gray T, Li W, Campbell P, Jha S, Radley S. Evaluation of coital incontinence by electronic questionnaire: prevalence, 
associations and outcomes in women attending a urogynaecology clinic. International Urogynecology Journal. 2018 
Jul 1;29(7):969-78. 
2. Gray T, Strickland S, Pooranawattanakul S, Li W, Campbell P, Jones G, Radley S. What are the concerns and goals of 
women attending a urogynaecology clinic? Content analysis of free-text data from an electronic pelvic floor 
assessment questionnaire (ePAQ-PF). International Urogynecology Journal. 2018 Jun 27:1-9. 
3. Gray T, Money-Taylor J, Li W, Farkas AG, Campbell P, Radley SC. What is the effect of body mass index on subjective 
outcome following vaginal hysterectomy for prolapse? International Neurourology Journal. 2019;23(2):1-8. 
https://doi.org/10.5213/inj.1938016.008 pISSN 2093-4777 · eISSN 2093-6931  
 
I agree to the inclusion of the above listed published research article in Dr Thomas Gray’s MD by publication thesis, to be submitted to the 
University of Sheffield.  
Name: Weiguang Li 
 
Signed:  
 
Date:  
 
